Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Catherine who wrote (3727)	11/24/2000 8:04:05 PM
From: TI2, TechInvestorToo	Read Replies (1) \| Respond to of 5665

Catherine, I talked with Jim at Stephens conference and John was at the IMGN Q&A session after the presentation. I am a subscriber and thanked them for IMGN and said it compensated (atoned) for XOMA. I bought XOMA when they had reccommended at 30 and that was the high. I saw Jim on TV cheering for XOMA then (1990?). I think they have become more cautious with recco having watched them over the years. It was clear that they still like the company. At the time IMGN was up to the 20's and Jim asked me, "Kind of makes you nervous, doesn't?" I agreed. Since then we went much higher and back. Although I am very bullish long on IMGN-I also am seasoned by market volatility and realize that we are still a long time from approved drugs. Why not call them. I have found them to be reasonably conversational. GLPAL TI2